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Phytochemicals have been presumed to possess prophylactic and curative properties in several pathologies, such as arsenic- (As-)
induced immunosuppression. Our aim was to discover a lymphoprotective extract from Lantana grisebachii Stuck. (Verbenaceae)
(LG). We assessed its bioactivity and chemical composition using cell-based assays. Fractions produced from a hexane extract
acutely induced nitrite formation in T-activated cell cultures (𝑃 < 0.0001). Water extraction released a fraction lacking nitrite
inducing activity in both lymphocyte types. Aqueous LG was found to be safe in proliferated and proliferating cells. The
infusion-derived extract presented better antioxidant capacity in proportion to phenolic amount in lymphocytes (infusive LG-
1i at 100 𝜇g/mL), which protected them against in vitro As-induced lymphotoxicity (𝑃 < 0.0001). This infusive LG phytoextract
contained 10.23 ± 0.43mg/g of phenolics, with 58.46% being flavonoids. Among the phenolics, the only predominant compound
was 0.723mg of chlorogenic acid per gram of dry plant, in addition to 10 unknown minor compounds. A fatty acid profile was
assessed. It contained one-third of saturated fatty acids, one-third of 𝜔9, followed by 𝜔6 (∼24%) and 𝜔3 (∼4%), and scarce 𝜔7.
Summing up, L. grisebachii was a source of bioactive and lymphoprotective compounds, which could counteract As-toxicity. This
supports its phytomedical use and research in order to reduce As-related dysfunctions.
1. Introduction
Many Argentinean plant species have been proposed as
sources of bioactive compounds thatmight be used to prevent
and treat several human health pathologies [1]. Among
these compounds, phenolics are the main candidates for
this biomedical potential, given their antioxidant and multi-
target effects. These processes involve xenohormesis, which
is an organic enhancement of cellular resistance against
oxidative stress acquired by consuming plant-synthesized
compounds [2]. Oxidative stress underlies numerous chronic
dysfunctions by triggering a redox imbalance with free
radical overproduction (reactive species of O, N, or S)
and impairment of antioxidant defence [3]. Reactive species
can be generated endogenously by cellular mechanisms or
be induced exogenously by environmental agents, such as
pollutants (e.g., arsenic, pesticides, etc.) [4].
The immune system involves a complex integration of
biological defences intended to protect an organism against
numerous pathogens, with B and T lymphocytes being the
crucial cells involved [5]. Given that the immune system is
one of the main targets affected by environmental oxidants
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(secondary immunosuppression), immune recovery might
be achieved by implementing certain bioactive phytochem-
icals with immunoxenohormetic activity [6]. Accordingly,
antioxidants could be used as chemopreventive immunoreg-
ulatory agents against chemically induced stress. A classic
example is chronic hydroarsenicism or arsenicosis: a mul-
tisystem syndrome due to prolonged arsenic intake from
drinking water. Worldwide, it presents high sanitary impact.
Arsenic impairs the redox response of cells leading to oxida-
tive damage by bottom-up cytotoxicity [7], with immuno-
toxic effects impairing cellular and antibody responses [8].
Furthermore, it exacerbates the inflammatory response [9].
In this area, phytopharmacological bioprospecting in
Argentina is promising. Several potentially beneficial species
inhabit in the mountainous region of central Argentina. Lan-
tana grisebachii Stuck. ex Seckt. var. grisebachii (Verbenaceae)
was selected after ethnopharmacological and experimental
studies. Infusions of the aerial parts of this plant are tradi-
tional gastrointestinal stimulants, as they improve toxin clear-
ance and possess antipyretic and antimicrobial activities [10].
All of this suggests an immunoactive potential. In addition,
it exhibits antioxidant activity in food and prevents in vitro
arsenic nephrotoxicity [11]. From these studies, this species
has been proposed as sources of polyphenols [12]. Among
these bioactive molecules, phenolic acids and flavonoids are
themost extensive groups with antioxidant properties, whose
acquisition depends on genetic, environmental, and technical
variables [13].
The aim of this study was to develop an anti-As extract
from L. grisebachii (LG), through establishing its bioactivity
with cell-based assays and then its chemical composition.
Specific objectives were to assess optimal extraction method,
redox safety, and antioxidant and lymphoprotective effects.
2. Materials and Methods
2.1. Plant Processing. Argentinean Lantana grisebachii (LG)
of the Chaquenian phytogeographic region [14] was collected
in summer (GPS coordinates: −31.28, −64.44), after obtain-
ing government consent by MinCyT-Cba. Specimens were
deposited in the RIOC Herbarium (UNRC, Argentina). One
gram of pulverized, air-dried aerial parts was extracted in
the dark at room temperature under constant shaking with
4mL of hexane (LG-24h: hexanic extraction), water (LG-
24m: 24 h aqueous maceration), or water initially at 95∘C
(LG-1i: 1 h aqueous infusion). Then, extracts were recovered
from the supernatants by filtration (0.45𝜇m HAWG04756
filters, Millipore, Brazil) and 24 h lyophilisation to be later
dissolved in 50% dimethylsulfoxide (Sigma, USA).
2.2. Animal Care and Cell Culture. Wistar rats (𝑛 ≥ 6) of
both sexes were cared for according to US ethical guidelines
and bred under standard laboratory conditions with ad
libitum potable <0.01mgAs/L water (Aguas Cordobesas SA,
Argentina) and commercial food (fatty acid profile: 14 : 0
(1.3%), 14 : 1 𝜔9 (1.8%), 16 : 0 (21%), 16 : 1 𝜔7 (0.6%), 18 : 0
(26%), 18 : 1 𝜔9 (11.5%), 18 : 2 𝜔6 (23.8%), 18 : 3 𝜔3 (2.1%),
20 : 1 𝜔9 (0.5%), 20 : 2 𝜔6 (1.3%), 20 : 4 𝜔6 (0.2%), 20 : 5 𝜔3
(6.7%), and 22 : 1 𝜔9 (0.2%)) (Cargill SACI, Argentina). After
that, splenocytes were obtained bymechanical dispersion and
chemical haemolysis of the spleens, and they were cultured at
37∘C in a 5% CO
2
atmosphere in a RPMI-1640 medium with
10% foetal bovine serum, 100 𝜇M ciprofloxacin, and 50𝜇M
2-mercaptoethanol (Sigma, USA). Then, ex vivo mitogen-
induced activation (EVMIA) was achieved by treating 1000
cells/𝜇L with 5 𝜇g/mL of concanavalin A or lipopolysaccha-
ride for 72 hours, to induce T-or B-activated splenocytes,
respectively. All outcomes were standardized by results in
unstimulated cell cultures, with a 72 h limit proliferation.
2.3. Experimental Design
2.3.1. Identification of Safe Fractions. First, the effects of polar
and nonpolar LG fractions (200𝜇g/mL, 2 h) were compared
in already stimulated splenocytes (after EVMIA) to discard
intrinsic extract toxicity. After the polar fraction was shown
to be safe, aqueous extracts were studied in dividing cells
(during all EVMIA; 100 𝜇g/mL, 3 d). Also, given that in vivo
insults could affect responses, two cell sources were used:
C (control group) and As (2-month orally exposed rats to
5mg/Kg/d of As from NaAsO
2
, Anedra Lab, Argentina).
These conditions were an accepted rat model of arsenicosis
[15], with nitrites being oxidative (61% correlated to free
radicals) and inflammatory biomarkers.
2.3.2. Identification of an Efficient Extract. Redox efficiency
(see below) of the safe aqueous fractions (100 𝜇g/mL, 3 d) was
tested during EVMIA.
2.3.3. Assessment of Direct In Vitro Protective Activity. The
most efficient and safe phytoextract was assayed during
EVMIA in cells exposed to 0–7.5 𝜇g/mL of As, with these
conditions triggering high toxicity and allowing screening
protective agents [16].
2.4. Biological Tests
2.4.1. Cellular Viability. Since the Trypan blue exclusion test
is not a sufficient determination of viability, a resazurin-based
assay was employed. Viable cells were stained with resazurin
(0.05mg/mL in culture medium, 6–12 h; TOX-8 kit, Sigma-
Aldrich, USA) [17]. Then, viability was calculated as the
percentage of absorbance at 600 nm with respect to control
(C = 100%). Absorbance readings were performed with
a GloMax-Multi microplate multimode reader (Promega
Corp., USA).
2.4.2. Cellular Nitrites. Nitrites, used as nitrosative stress
markers, were assayed by the Griess reaction [18], with reac-
tants purchased byWiener Lab (Argentina). Cell suspensions
reacted with equal volumes of 0.1% naphthylethylenediamine
dihydrochloride and 1% sulphanilamide in 0.1 N HCl (room
temperature, 15min). Percentages were calculated from a
standard sodium nitrite curve (at 550 nm).
Advances in Pharmacological Sciences 3
2.4.3. Free Radical Activity. Radicals oxidized an ethano-
lic 16mM N,N,N󸀠,N󸀠-tetramethyl-p-phenylenediamine-1,4-
dihydrochloride solution (Sigma, USA) to be read at 540 nm
[3]. Equal volumes of cell sample and solution reacted for
30min in an oxygen-free environment at room temperature.
Percentages, with respect to control, were used to calculate
redox efficiency as the quotient of radical activity (%) over
the extract phenolic content (%).
2.5. Phytochemistry
2.5.1. Total Phenolics. A solution was created with 25𝜇L of
extract, 25 𝜇L of 2N Folin-Ciocalteau (Anedra, Argentina),
and 150 𝜇L of water, and then 50𝜇L of saturated sodium
bicarbonate solutionwas added. After 30min of incubation at
37∘C in the dark, absorbance was recorded at 750 nm [19]. A
standard curve was used to calculate mg equivalents of gallic
acid per gram of dry extract (mg/g). Gallic acid was from
Riedel-de-Hae¨n (China).
2.5.2. Total Flavonoids. Flavones and flavonols were deter-
mined as follows [20]: 50𝜇L of extract was incubated for
30min at room temperature with 150 𝜇L of ethanol (96%)
(Cicarelli, Argentina), 10 𝜇L of aluminium chloride (10%),
10 𝜇L of potassium acetate (1M) (Anedra, Argentina), and
150 𝜇L of water. Results were calculated at 415 nm as mg
equivalents of quercetin dihydrate per gram of dry extract
(mg/g) using a standard curve (Fluka, UK).
2.5.3. Phenolic Analysis. Phenolics were analyzed by high
performance liquid chromatography with diode array detec-
tion with a HPLC-DAD Agilent Technologies 1200 Series
system equipped with Agilent G1312B SL Binary gradient
pump, Agilent G1379 B solvent degasser, Agilent G1367
D SL + WP autosampler, and Agilent G1315 C Starlight
DAD (ISIDSA, UNC). Separation was achieved on a LUNA
reversed-phase C18 column (5 𝜇m, 250mm × 4.60mm i.d.;
Phenomenex, USA), set at 35∘C using an Agilent G1316 B
column heater module. The mobile phase was 0.5% formic
acid (Fluka, Germany) in ultrapure water (<5 𝜇gL-1 TOC;
Sartorius, Germany) (vv-1, solvent A) and 0.5% formic acid
in methanol (Baker, Mex.) (vv-1, solvent B). It began at 20%,
rising to 50% B in a period of 3min, maintained for 5min,
followed by a second increase to 70% B in the course of
7min, maintained for 5min, and a third increase to 80%
B in 1min, maintained for 9min, remaining at this last
concentration for 10min before being run. The flow rate was
0.4mL/min, injecting 40 𝜇L into the column. DADwas set at
280, 320, and 350 nm as preferred wavelengths and the UV-
Vis spectra were 200–600 nm. Standards were ferulic acid and
caffeic acids (Extrasynthese, France), naringin, kaempferol,
and p-coumaric acid (Fluka, UK), and chlorogenic acid,
naringenin, myricetin, trans-resveratrol, and rutin (Sigma-
Aldrich, Germany).
2.5.4. Fatty Acid Profile. Lipids were taken from the lower
phase of a Fo¨lch extraction, whichwas dried under a nitrogen
flow and methylated with toluene and sodium methoxide
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Figure 1: Nitrite% in T- and B-activated cultures treated for 2 hwith
200 𝜇g/mL of L. grisebachii extracts. Results were averaged from
three separate experiments ( ∗𝑃 < 0.01).
(Sigma, USA) at room temperature for 24 hours. Then,
fatty acid methyl esters were dissolved in 50% hexane and
recovered from the hexane phase to be dried in nitrogen and
suspended in hexane. Separation was achieved in a Supelco
fused silica capillary column (30m × 0.25mm × 0.25 𝜇m),
with a 20 cm/s nitrogen flow rate (mobile phase) and 2∘C/min
gradient. A Perkin Elmer 500 CLARUS GLC chromatograph
with flame ionization detection (Waltham, USA) was used
for analysis (oven program: 180∘C–240∘C). The standard was
from NU-Chek-Prep Inc. (USA) and results were expressed
as percentages of total fatty acid content.
2.6. Statistical Analysis. Data were expressed as mean ±
standard error (SE) from at least three separate experiments
performed in triplicate, unless otherwise noted. ANOVA
models were used to evaluate differences between treatments,
followed by Tukey’s test for mean comparisons. Then, GLM
were suited to regress the effects of experimental conditions
(𝑃 < 0.05). Analyses were performed with the InfoStat 2012
software (InfoStat Group, Argentina).
3. Results
3.1. Bioguided Extract Selection
3.1.1. Extraction. Given that solvent polarity determines the
type of extracted compounds, hexane and water were com-
pared. Hexanic L. grisebachii extraction produced an organic
fraction that induced nitrite formation in T-activated cultures
during the acute assay (𝑃 < 0.0001). On the other hand,
water extraction released an aqueous fraction without nitrite
inducing activity in either lymphocyte type.Thus, these polar
derivatives were also safe for B- and T-activated cells, which
came from in vivo As-exposed animals; that is, their safety
was an exposure-independent effect and found in proliferated
and proliferating cells (Figures 1 and 2). Therefore, aqueous
extracts were selected for the next stage.
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Figure 2: Nitrite % in T- and B-activated cultures from control
(C) and arsenic-exposed rats (As), treated for 72 h with 100𝜇g/mL
of aqueous L. grisebachii extracts (LG-24m: cold 24 h maceration
versus LG-1i: hot 1 h infusion) or without them. Results were
averaged from three separate experiments ( ∗𝑃 < 0.01).
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Figure 3: Redox efficiency (cell free radical level/extract phenolic
content) of 100 𝜇g/mL aqueous L. grisebachii extracts (LG-24m: cold
24 hmaceration versus LG-1i: hot 1 h infusion) in T- and B-activated
cultures treated for 72 h. Results were averaged from three separate
experiments ( ∗𝑃 < 0.01).
3.1.2. Redox Efficiency. Given that higher temperature pro-
motes molecular mobility, caloric changes of water could
modify the extraction profile. The 24 h water-macerated
extract demonstrated higher quotients than the infusive
extract (𝑃 < 0.01), without arsenic-related differences; that
is, the last extract showed a better antioxidant capacity per
phenolic amount in all cell cultures (Figure 3). Thus, the
infusive fraction was selected.
3.1.3. Protection against Arsenotoxicity. Given that in vivo As
exposure has been related to a decrease in splenocyte viability,
an in vitro assaying of L. grisebachii to explore its potential
to combat this toxin was encouraged. First, arsenic dose-
dependent toxicity was confirmed (concentrations as low as
0.075𝜇g/mL) (𝑃 < 0.05). In this case, the infusive extract
counteracted such toxicity in a dose-dependent manner
(Figure 4) with 100 𝜇g/mL reducing cell death at all As
concentrations (including 7.5 𝜇g/mL) (𝑃 < 0.0001). The
dose of 10 𝜇g/mL was protective up to 0.075𝜇g/mL of As in
both cell types. On the other hand, B-activated splenocytes
were protected up to 0.75𝜇g/mL of As, indicating increased
resistance. Lower extract concentrations were not sufficient
to prevent As-induced damage related to oxidant induction
(𝑃 < 0.05). T-activated cells weremore liable thanB-activated
ones (111.24 ± 0.40% versus 100.00 ± 0.73%, resp.) (𝑃 <
0.005), whereas the infusive extract was antioxidant in both
(𝑃 < 0.01).
3.2. Phytochemistry of the Selected Infusive Lantana
grisebachii Extract
3.2.1. Phenolics. It is known that solvent polarity and tem-
perature determine extraction outcome. The employment
of water yielded 1.67 times more phenolic extraction from
LG than hexane (distinct polarities) after 24 h maceration at
room temperature (𝑃 < 0.05). Also, water extraction could be
reduced to 1 hour by increasing its temperature. This method
increased phenolic extraction 1.55 times over the classic
24 h water maceration, with extraction being temperature
dependent (𝑃 < 0.02). This infusive phytoextract contained
10.23 ± 0.43mg/g of phenolics, with 58.46% of flavonoids
(05.98 ± 0.12mg/g). Among phenolics, chlorogenic acid
was the predominant compound (0.723mg/g), among 10
unknown minor compounds (Figure 5).
3.2.2. Lipids. Increased water temperature allows some
organic compounds to be extracted; thus, a fatty acid fin-
gerprint could be assessed. The result showed one-third of
saturated fatty acids, one-third of 𝜔9, 𝜔6 (∼24%), and 𝜔3
(∼4%), and scarce 𝜔7 (Figure 5).
4. Discussion
This study pursued the bioguided identification of a plant
extract of L. grisebachii (LG) that could combat As lym-
photoxicity by comparing different extraction methods and
lymphocyte responses (nitrites, free radicals, and cellular
viability).
The phenolic increase found in aqueous LG extracts was
caused by the presence of principal bioactive molecules,
such as flavonoids and phenolic acids (chlorogenic). This
was enhanced by the use of heated water, thus improv-
ing extraction [21]. Although hydrophilic organic solvents
(e.g., ethanol) are usually utilized to obtain these kinds
of compounds [22], a pharmacological equivalency has
been demonstrated between alcoholic extracts and those
derived from infusions [23]. Therefore, flavonoids become
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bioavailable in humans due to the presence of functional
chemical groups (e.g., hydrophilic hydroxyl and carbonyl)
in their polycyclic structures [24]. Moreover, the better
redox efficiency of infusions with respect to the other cold
water-macerated extracts indicated qualitative differences
with greater bioactivity per weight. This might be related to
extraction of hydrosoluble thermostable antioxidants from
plants [25]. Furthermore, organic extracts of other plants
have been reported as antioxidants and cytoprotectors but in
a lesser extent than their aqueous counterparts [26]. In this
study, an elevation of nitrites was seen in cell cultures treated
with the hexanic extract, which correlated with phenolic
decrease. Concerning this, LG metabolome might present
apolar oxidants (e.g., nitrosative inducers, oxygenated fatty
acids) [27, 28].
Given that lymphocyte response can be affected by
different factors (e.g., cell cycle progression, environmental
exposure, etc.), the safety of aqueous extracts was reevaluated.
Proliferating lymphocytes were more susceptible to oxidative
stress induced by As, as was expected [29]. Nevertheless,
aqueous extracts were safe in all lymphocyte cultures. Also,
the infusive antioxidant phytoextract of Lantana grisebachii
triggered a xenohormetic defence against arsenic lympho-
toxicity. Some of the pathways involved in such protection
have been established [30]. Also, differences between T-
and B-activated splenocytes have shown higher B resistance
to chemical/environmental stress related to their reduced
biologically conditioned susceptibility [31, 32]. Furthermore,
the extract may contain B lymphoproliferative compounds
such as other plant phenolic derivatives [33]. On other hand,
the involvement of apoptosis as the primary lymphotoxic
effect has been demonstrated in extenso under the assayed
conditions [34]; thus, lethal phenotype was not searched (in
fact, late determinations in cell culture end could lead to
confusions about the initial type). Therefore, a cell-based
method for high throughput screenings of phytodrugs was
selected [35] due to its representativeness of immune cell
response and apoptosis [36].
These multiple effects (antioxidation, cytoprotection, and
functional induction) have been seen in other in vitro sys-
tems. For example, 100 𝜇g/mL LG-1i promoted kidney cells
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of Cercopithecus aethiops (viability with respect to control:
104.67 ± 0.05%) with decreased 𝛾-glutamyl transpeptidase
activity after being treated for 2 h (control: 27.95 ± 1.55
versus LG-1i: 22.50 ± 0.51 nIU/cell, 𝑃 < 0.05) and 4 h
(control: 31.60 ± 0.64 versus LG-1i: 23.15 ± 0.64 nIU/cell,
𝑃 < 0.05) (unpublished data). This cell type was the first
one where cytoprotective LG was discovered to prevent As-
induced oxidative stress [11], with the enzyme being a cell
response to augment redox resistance [37]. This supported
that phytodrugs (e.g., flavonoid-related compounds, flavolig-
nanes) can stimulate molecular protective pathways [38].
Also, the beneficial effects of Lantana grisebachii infusion in
both murine lymphocytes and monkey renocytes indicated
that they were independent of species and cell types; that is, a
general antioxidant bioactivity was found for this plant.
Given that temperature favours lipid kinetics in aqueous
biological samples [39], solvent heating was mandatory to
extract them from plant material during water extraction,
with fatty acid assessment in a plant infusion being inno-
vative. In fact, the extraction enhancement achieved by
heating water was manifested by the presence of lipids in
an aqueous infusion.Thismethodological approach favoured
unsaturated fatty acids obtaining, including some essential
ones for immunological responses, which are highly sensitive
to arsenic-induced dysfunctions and disturbances [30].
5. Conclusion
Although further studies are required in order to establish
other functional implications for lymphocytes, this study
provides, for the first time, the basis to develop Lantana grise-
bachii-derived phytodrugs to reduce dysfunctions induced by
arsenic, a well-known oxidative immunotoxic. In this regard,
arsenicosis is a public health concern worldwide, despite
efforts to remedy contaminated soil and water, with immune
cells being major targets. Accordingly, sequential bioguided
bioprospecting of antioxidant plants, such as Lantana grise-
bachii, is a valuable approach. Moreover, the mentioned
plant is immunoactive and common in Argentine flora,
whichmight represent an abundant source of compounds for
phytopharmaceutical development by easy extraction using a
water-based photoprotected thermoassisted method.
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